Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Keefe, Bruyette & Woods raised the price target for Fifth Third Bancorp (NYSE:FITB) from $58 to $60. Keefe, Bruyette & Woods analyst Christopher McGratty maintained a Market Perform rating. Fifth Third Bancorp shares closed at $58.01 on Friday. See how other analysts view this stock.
HC Wainwright & Co. boosted Trevi Therapeutics Inc (NASDAQ:TRVI) price target from $21 to $24. HC Wainwright & Co. analyst Brandon Folkes maintained a Buy rating. Trevi Therapeutics shares closed at $19.07 on Friday. See how other analysts view this stock.
Needham boosted price target for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) from $255 to $282. Needham analyst Ami Fadia maintained a Buy rating. Jazz Pharmaceuticals shares closed at $247.53 on Friday. See how other analysts view this stock.
Morgan Stanley raised the price target for Global Payments Inc (NYSE:GPN) from $65 to $100. Morgan Stanley analyst James Faucette upgraded the stock from Equal-Weight to Overweight. Global Payments shares closed at $77.82 on Friday. See how other analysts view this stock.
